Kati Mokkala

Dr. Kati Mokkala

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
OPOuti Pellonperä
Outi Pellonperä
KMKati Mokkala
Kati Mokkala
NHNoora Houttu
Noora Houttu
TVTero Vahlberg
Tero Vahlberg
Ella KoivuniemiElla Koivuniemi
Ella Koivuniemi
KLKirsi Laitinen
Kirsi Laitinen
OBJECTIVE To assess whether the risk of gestational diabetes mellitus (GDM) may be lowered and glucose metabolism improved by daily administration of fish oil and/or probiotic supplements in overweight and obese pregnant women. RESEARCH DESIGN AND METHODS We randomized in a double-blind manner 439 women (mean 13.9 ± 2.1 gestational weeks [gw]) into four intervention groups: fish oil + placebo, probiotics + placebo, fish oil + probiotics, and placebo + placebo. Fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid) and probiotic supplements (Lactobacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 1010 colony-forming units each) were provided for daily consumption from randomization beyond delivery. Primary outcomes were the incidence of GDM diagnosed with oral glucose tolerance test targeted at 24–28 gw and the change in fasting glucose between randomization and late pregnancy (mean 35.2 ± 0.9 gw). Insulin concentration, insulin resistance HOMA2-IR index, and pregnancy outcomes were determined, as were adverse effects related to the intervention. Analyses were by intent to treat. RESULTS No differences were found among the intervention groups in the maternal and neonatal pregnancy outcomes or side effects related to the intervention (P > 0.05). The proportion of women with GDM (94 of 377; fish oil + placebo, 23 of 96, 24.0%; probiotics + placebo, 25 of 99, 25.3%; fish oil + probiotics, 26 of 91, 28.6%; and placebo + placebo, 20 of 91, 22.0%) and the change in glucose, insulin, or HOMA2-IR (n = 364) did not differ among the intervention groups (P > 0.11 for all comparisons). CONCLUSIONS An intervention with fish oil and/or probiotics during pregnancy seemed to be both safe and well tolerated but conferred no benefits in lowering the risk of GDM or improving glucose metabolism in overweight and obese women.

1 September 2016 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
KMKati Mokkala
Kati Mokkala
HRHenna Röytiö
Henna Röytiö
EMEveliina Munukka
Eveliina Munukka
SPSami Pietilä
Sami Pietilä
UEUlla Ekblad
Ulla Ekblad
KLKirsi Laitinen
Kirsi Laitinen
Background: Increased intestinal permeability may precede adverse metabolic conditions. The extent to which the composition of the gut microbiota and

Verified
Journal Article
Open access
PDF file
KLKirsi Laitinen
Kirsi Laitinen
KMKati Mokkala
Kati Mokkala
Disturbances in gut microbiota homeostasis may have metabolic consequences with potentially serious clinical manifestations. Diet influences the host’s metabolic health in several ways, either directly or indirectly by modulating the composition and function of gut microbiota. This study investigated the extent to which dietary quality is reflected in gut microbiota diversity in overweight and obese pregnant women at risk for metabolic complications. Dietary quality was measured by a validated index of diet quality (IDQ) and microbiota composition was analyzed using 16SrRNA gene sequencing from 84 women pregnant less than 18 weeks. The alpha diversity, measured as Chao1, observed operational taxonomic units (OTUs), phylogenetic diversity, and the Shannon index were calculated. The IDQ score correlated positively with the Shannon index (rho = 0.319, p = 0.003), but not with the other indexes. The women who had the highest dietary quality (highest IDQ quartile) had higher gut microbiota diversity in all the investigated indexes, when compared to the women with the lowest dietary quality (lowest IDQ quartile; p < 0.032). Consequently, a higher dietary quality was reflected in a higher gut microbiota diversity. The presented approach may aid in devising new tools for dietary counseling aiming at holistic health, as well as in microbiome studies, to control for dietary variance.

24 August 2020 in Gut
Verified
Journal Article
Closed access
PDF file
KMKati Mokkala
Kati Mokkala
NPNiklas Paulin
Niklas Paulin
NHNoora Houttu
Noora Houttu
Ella KoivuniemiElla Koivuniemi
Ella Koivuniemi
OPOuti Pellonperä
Outi Pellonperä
KLKirsi Laitinen
Kirsi Laitinen
Objective: Gut microbiota and diet are known to contribute to human metabolism. We investigated whether the metagenomic gut microbiota composition and function changes over pregnancy are related to gestational diabetes mellitus (GDM) and can be modified by dietary supplements, fish oil and/or probiotics. Design: The gut microbiota of 270 overweight/obese women participating in a mother–infant clinical study were analysed with metagenomics approach in early (mean gestational weeks 13.9) and late (gestational weeks 35.2) pregnancy. GDM was diagnosed with a 2 hour 75 g oral glucose tolerance test. Results: Unlike women with GDM, women without GDM manifested changes in relative abundance of bacterial species over the pregnancy, particularly those receiving the fish oil + probiotics combination. The specific bacterial species or function did not predict the onset of GDM nor did it differ according to GDM status, except for the higher abundance of Ruminococcus obeum in late pregnancy in the combination group in women with GDM compared with women without GDM. In the combination group, weak decreases over the pregnancy were observed in basic bacterial housekeeping functions. Conclusions: The specific gut microbiota species do not contribute to GDM in overweight/obese women. Nevertheless, the GDM status may disturb maternal gut microbiota flexibility and thus limit the capacity of women with GDM to respond to diet, as evidenced by alterations in gut microbiota observed only in women without GDM. These findings may be important when considering the metabolic complications during pregnancy, but further studies with larger populations are called for to verify the findings.

1 April 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
KMKati Mokkala
Kati Mokkala
NHNoora Houttu
Noora Houttu
TCTuğçe Cansev
Tuğçe Cansev
KLKirsi Laitinen
Kirsi Laitinen

1 April 2017 in Metabolism
Verified
Journal Article
Closed access
KMKati Mokkala
Kati Mokkala
OPOuti Pellonperä
Outi Pellonperä
HRHenna Röytiö
Henna Röytiö
PPPirkko Pussinen
Pirkko Pussinen
TRTapani Rönnemaa
Tapani Rönnemaa
KLKirsi Laitinen
Kirsi Laitinen